Case Comprehensive Cancer Center

Vitamin B3 could be making chemotherapy less effective in pancreatic cancer patients

The 2026 Annual Meeting of the Translational Research Cancer Centers Consortium (TRCCC): Forging Ahead in the Era of Immunotherapy went off without a hitch thanks to this year’s host, Case Comprehensive Cancer Center (Case CCC).Taking place Feb. 25–27 at Seven Springs Mountain Resort in…

Since Erin Henninger experienced her first extended reality (XR) headset in 2014, she has worked with Case Western Reserve University’s Interactive Commons to prepare for a future where students could leverage XR-type devices in their studies. Now, as executive director of the Interactive…

Finding an effective treatment for osteosarcoma, the most common type of bone cancer in children and young adults, has puzzled medical researchers for 40 years. Now, a new study by researchers at Case Western Reserve University and University Hospitals shows some promising results. The…

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving therapy. In a study recently published in Molecular Imaging and Biology, the researchers describe…

When J. Alan Diehl arrived at Case Western Reserve University in 2019, the Department of Biochemistry in the School of Medicine was at a crossroads—ready for a renewed sense of purpose and direction. Six years later, under Diehl’s leadership as chair, the department’s faculty headcount has more…

Case Western Reserve University researchers reveal cell development role for two ‘epigenetic’ markers, opening door for new treatment for leukemia

The Case Comprehensive Cancer Center (Case CCC), designated a comprehensive consortium cancer center by the National Cancer Institute (NCI) of the National Institutes of Health, has received a $25.5 million Cancer Center Support Grant from NCI. The renewal marks 38 years of continuous NCI funding,…

Continuing an esteemed family legacy of cancer science is no small feat—but Gary Schwartz, MD, carries on with aplomb. Case CCC's Director for two years, three months, and seven days (but who's counting), he was appointed the inaugural Peter and Laurie Weinberger Professorship in Cancer Research…

Educating the next generation of cancer researchers